AAV-PGIS gene transfer improves hypoxia-induced pulmonary hypertension in mice.
暂无分享,去创建一个
K. Kimura | S. Ogawa | K. Fukuda | T. Shimada | H. Mochizuki | C. Yokoyama | T. Tanabe | T. Satoh | M. Ieda | H. Kanazawa | T. Kawakami | Yasuyo Ieda | Kensuke Kimura | Takashi Kawakami
[1] S. Miyachi,et al. Neuronal specificity of α-synuclein toxicity and effect of Parkin co-expression in primates , 2007, Neuroscience.
[2] O. Danos,et al. Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice , 2006, Gene Therapy.
[3] J. Rasko,et al. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response , 2006, Nature Medicine.
[4] S. Ogawa,et al. A long-acting prostacyclin agonist with thromboxane inhibitory activity for pulmonary hypertension. , 2005, American journal of respiratory and critical care medicine.
[5] S. Archer,et al. Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension. , 2005, The Journal of clinical investigation.
[6] D. Stewart,et al. Rescue of Monocrotaline-Induced Pulmonary Arterial Hypertension Using Bone Marrow–Derived Endothelial-Like Progenitor Cells: Efficacy of Combined Cell and eNOS Gene Therapy in Established Disease , 2005, Circulation research.
[7] Bing Wang,et al. Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart , 2005, Nature Biotechnology.
[8] K. Okumura,et al. Repeated gene transfer of naked prostacyclin synthase plasmid into skeletal muscles attenuates monocrotaline-induced pulmonary hypertension and prolongs survival in rats. , 2004, Human gene therapy.
[9] H. Matsuda,et al. Gene transfer of human prostacyclin synthase into the liver is effective for the treatment of pulmonary hypertension in rats. , 2002, The Journal of thoracic and cardiovascular surgery.
[10] D. Eidelberg,et al. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation. , 2001, Human gene therapy.
[11] T. Ogihara,et al. Gene Transfer of Human Prostacyclin Synthase Ameliorates Monocrotaline-Induced Pulmonary Hypertension in Rats , 2000, Circulation.
[12] N. Voelkel,et al. Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension. , 1999, The Journal of clinical investigation.
[13] T. Flotte,et al. Efficient and persistent gene transfer of AAV-CFTR in maxillary sinus , 1998, The Lancet.
[14] V. Ullrich,et al. Molecular cloning and expression of human prostacyclin synthase. , 1994, Biochemical and biophysical research communications.
[15] L. Rubin,et al. Primary pulmonary hypertension. , 1997, The New England journal of medicine.
[16] E H Bergofsky,et al. Primary pulmonary hypertension. A national prospective study. , 1987, Annals of internal medicine.
[17] T. Tonai,et al. Enzyme immunoassay of 6-ketoprostaglandin F1α in a solid phase , 1985 .